We asked our biopharma readers about their company's policies on vaccine mandates. Feelings are running strong
The rapid adoption of Covid-19 vaccine mandates by several Big Pharma multinationals enjoys broad support in the biopharma industry as people return to the office. But it’s clear that there are some deep-seated objections among some and no clear consensus on the need for putting mandates in place for everyone.
That’s the bottom line from our snap survey over the last 2 days. We asked our biopharma subscribers whether their companies had a mandate in place and whether or not they agreed that vaccines should be required. Paul Hastings, the CEO of Nkarta and chairperson of BIO — and an enthusiastic supporter of mandates — also helped spread the link to the poll among the organization’s membership.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.